Template:Lungs and lymph nodes

From patholines.org
Jump to navigation Jump to search

Lungs

Author: Mikael Häggström [note 1]

Basic microscopic screening

For screening of lung autopsies, see Lung autopsy

Mainly look for carcinoma. Further information: Lung tumor

If granulomas are seen, generally stain for acid-fast bacteria and fungi.

Common findings

Active searching for them is not mandatory.

  • Emphysema (enlarged alveoli). Reporting is optional in mild cases in the elderly.

  • Anthracosis (interstitial black material).

  • Respiratory epithelial shedding in a small bronchus. If present, look for vascular leakage, mucus hypersecretion and/or widespread airway narrowing, together indicating asthma.[1]

Other pertinent findings

  • hyaline membranes, suggesting diffuse alveolar damage.]]

Notes

  1. ↑ For a full list of contributors, see article history. Creators of images are attributed at the image description pages, seen by clicking on the images. See Patholines:Authorship for details.

Main page

References

  1. ↑ Madea, B (2014). Handbook of forensic medicine . Hoboken, N.J: Wiley-Blackwell. ISBN 978-1-118-57062-3. OCLC 872114659. 

Image sources


Lung tumor

Gross processing

As per presentation above.

Microscopic evaluation

Lung cancers by relative incidence.

Medical imaging provides a major clue as to whether a lung tumor is benign or malignant, where lesions smaller than 2 cm are likely to be benign, whereas lesions larger than 2 cm are malignant (that is, lung cancer) in 85% of cases.[1]

Benign tumors

Subsequently distribution of benign tumors and lung cancers, respectively, are as follows:[1]

Minute pulmonary meningothelial-like nodules (MPMNs) are interstitial nodular proliferations of small oval or spindle-shape cells in nests,[2] and do not need reporting.[image 1]

Benign lung tumors:

  • Hamartomas - 76%
  • Benign fibrous mesothelioma/solitary fibrous tumor (SFT) - 12.3%
  • Inflammatory pseudotumor (IPT) - 5.4%
  • Lipoma - 1.5%
  • Leiomyoma - 1.5%
  • Other - 3.3%

Lung cancers

TTF-1 needs to have nuclear staining on immunohistochemistry to count as positive. Cytoplasmic staining is disregarded for diagnostic purposes.[4]

Whereas large cell carcinoma is more often histologically distinct, adenocarcinoma and SCC may look alike. In such cases, an immunohistochemistry panel of TTF1, CK5/6, and p63 can be used to distinguish the two.[5][6]

Further workup

edit
For non-small cell carcinoma (NSCLC) stages IB - IV, generally perform full next generation sequencing panel (DNA and RNA) with PDL-1 immunostaining. For advanced stage NSCLC that are not candidates for biopsy or re-biopsy, “liquid biopsy” on peripheral blood is a viable option.

Notes


Main page

References

  1. ↑ 1.0 1.1 Alain C. Borczuk (2008). "Benign Tumors and Tumorlike Conditions of the Lung ". Archives of Pathology & Laboratory Medicine 132 (7). Archived from the original. . 
  2. ↑ Kuroki, Masaomi; Nakata, Hiroshi; Masuda, Toshifumi; Hashiguchi, Norihisa; Tamura, Shozo; Nabeshima, Kazuki; Matsuzaki, Yasunori; Onitsuka, Toshio (2002). "Minute Pulmonary Meningothelial-like Nodules: High-Resolution Computed Tomography and Pathologic Correlations ". Journal of Thoracic Imaging 17 (3): 227–229. doi:10.1097/00005382-200207000-00008. ISSN 0883-5993. 
  3. ↑ Dr Nicholas Turnbull, A/Prof Patrick Emanual (2014-05-03). Squamous cell carcinoma pathology. DermNetz.
  4. ↑ Image by Mikael Häggström, MD. Source for significance: Bejarano PA, Mousavi F (2003). "Incidence and significance of cytoplasmic thyroid transcription factor-1 immunoreactivity. ". Arch Pathol Lab Med 127 (2): 193-5. doi:10.5858/2003-127-193-IASOCT. PMID 12562233. Archived from the original. . 
  5. ↑ Inamura K (2018). "Update on Immunohistochemistry for the Diagnosis of Lung Cancer. ". Cancers (Basel) 10 (3). doi:10.3390/cancers10030072. PMID 29538329. PMC: 5876647. Archived from the original. . 
  6. ↑ Affandi KA, Tizen NMS, Mustangin M, Zin RRMRM (2018). "p40 Immunohistochemistry Is an Excellent Marker in Primary Lung Squamous Cell Carcinoma. ". J Pathol Transl Med 52 (5): 283-289. doi:10.4132/jptm.2018.08.14. PMID 30235512. PMC: 6166010. Archived from the original. . 

Image sources

  1. ↑ Image(s) by: Mikael Häggström, M.D. Public Domain
    - Author info
    - Reusing images

Lung wedge resection and lobectomy

Author: Mikael Häggström [note 1]

Comprehensiveness

On this resource, the following formatting is used for comprehensiveness:

  • Minimal depth
  • (Moderate depth)
  • ((Comprehensive))
Other legend

<< Decision needed between alternatives separated by / signs >>
{{Common findings / In case of findings}}
[[Comments]]
Link to another page

Intraoperative consultation

Perform:

  • Tumor microscopy on frozen sectioning if there is intermediate risk of cancer (if frozen section does not show cancer, the surgeon may not need to perform lymph node dissection)
  • Margin assessment: A gross distance from tumor to the parenchymal is generally sufficient, unless a suspected malignancy is close enough to confer a significant risk of extension to the margin, in which case the closest parenchymal margin should be frozen en face[note 2]. For lobectomies, generally perform frozen section on the bronchial and vascular margin en face[note 2].

Grossing

Surgical margin sampling of a lobectomy for intraoperative consultation.

Perform the following:[1]

  • Measure the specimen in 3 dimensions.
  • (Weigh lobectomies.).
  • Describe pleural surface, including color, and any presence of granularity, adhesions, retraction, or tumor.
  • Palpate for any tumors.
  • Ink the surgical margin and cut it away just below any sutures or staples. If the margin is substantially stapled (and their removal would be either too tissue-damaging or otherwise inconvenient), ink and use another section of the tissue underneath it for frozen sectioning.
  • In intraoperative consultations use a section that is presumably closest to a tumor for frozen sectioning, with the tissue en face[note 2], for radicality. This is generally enough to report intraoperatively to the surgeon, unless otherwise requested.
  • ((Sample the entire surgical margin for standard processing.))
  • Cut open the bronchi of the specimen with a pair of scissors, as far as they can fit within the lumina. Attempt to cut so as to be able to take a section that includes both any tumor and nearest bronchus. Palpate for tumors intermittently. Describe the cut surface, including color and consistency, and any focal lesions.
  • Turn the specimen to the side with least cuts so far, and serially section it. Palpate for tumors intermittently.
Initial measurements when
triaging fresh lobectomies
  • Size of lobe in 3 dimenstions
  • Size of tumor (in 3 dimensions)
  • (Weight)
  • Distance from tumor to closest
    parenchymal, bronchial and vascular margins
  • Measure tumor size as a maximum diameter (or 3 dimensions)
  • Determine location: Which lobe if applicable, and if it is peripheral, central or hilar.
  • Margin length to pleura and hilum/surgical margin.
  • Any involvement of major bronchi or blood vessels.
  • Describe any lymph nodes, including location, range of sizes and appearance of cut surface.

Tissue selection

Vascular (inked yellow), bronchial (inked blue) and parenchymal (inked black) margins of a lobectomy, showing staple line of bronchial margin being removed with scissors to allow for tissue selection.
  • 1 from bronchial and vascular margins, en face[note 2], if present, ((differentially inked))
  • 1 from nearest parenchymal margin, en face
  • Sections of any tumor
  • Any other focal change
  • 1 from random non-neoplastic lung tissue

Gross report

((A. Labeled - ___. The specimen is received fresh for intraoperative consultation and consists of)) of a right upper lobe of lung which measures __ x __ x __ cm (and weighs __ g). The specimen includes a bronchial stump measuring __ cm in length and __ cm in diameter, which grossly appears unremarkable. The pleural surface is mottled tan-pink {{and slightly puckered on the __ aspect}}. There is a staple line representing the parenchymal margin measuring __ cm in length. The stapled margin is inked black. (On opening the bronchial tree, the mucosa is tan and smooth and the lumens are patent. The blood vessels are opened to reveal no blood clot or tumor.) {{Cut section show an irregular, gray-tan, rubbery firm mass measuring __ x __ x __ cm. The tumor is located __ cm from the bronchial and vascular margin and __ cm from the nearest surgical margin. The tumor abuts smaller bronchi and vessels.}} The remaining parenchyma is pink and spongy. (No lymph nodes are identified in the peribronchial region.) (Representative sections are submitted for microscopic examination in __ cassettes.)

  • Squamous cell carcinoma involving a subsegmental bronchus with distal chronic obstructive pneumonia. The tumor is seen as a rounded nodule, approximately 2 cm in diameter, proximal to a more irregular focus of chronic obstructive pneumonia with fibrosis.

  See also: General notes on gross processing


Microscopic evaluation

Look mainly for carcinoma. Further information: Lung tumor

Microscopy report

Lung synoptic reports contain information (number and station) on all lymph nodes received per accession. For example, if Parts A-D are mediastinal nodes (8 in total) and Part E is a lobectomy containing 2 additional peribronchial nodes, the synoptic report for Part E should document all 10 nodes, for example:

A. Lymph node, station 1:
Negative for carcinoma. (0/1, 2 etc)

B. Lymph node, station 2:
Negative for carcinoma. (0/1, 2 etc)

C. Lobectomy, RLL: Adenocarcinoma

Size:
Histologic type
Margins

  See also: General notes on reporting


Notes

  1. ↑ For a full list of contributors, see article history. Creators of images are attributed at the image description pages, seen by clicking on the images. See Patholines:Authorship for details.
  2. ↑ 2.0 2.1 2.2 2.3 En face means that the section is tangential to the region of interest (such as a lesion) of a specimen. Further information: Gross_processing#Cutting

Main page

References

  1. ↑ Partially using the following procedure:. Pulmonary pathology grossing guidelines. Retrieved on 2021-03-17.

Image sources


Lymph nodes

Author: Mikael Häggström [note 1]

Comprehensiveness

On this resource, the following formatting is used for comprehensiveness:

  • Minimal depth
  • (Moderate depth)
  • ((Comprehensive))

Gross processing

If suspected lymphoma, before putting tissue in formalin, ensure that tissue is preserved in appropriate media for any special tests (usually flow cytometry). Further information: Lymphoma

In samples with tumors, slice through all included fat while palpating and looking for lymph nodes, and submit all that are found.

For lymph nodes taken for potential breast cancer metastasis, find out and report the procurement time and the time when put in formalin.[note 2]

Gross procedure

  • Measure the dimensions. For a lymph node with minimal surrounding fatty tissue, measure the greatest dimension (or 3 dimensions). For specimens with substantial amount of fatty tissue, measure the specimen in 3 dimensions, and measure the greatest dimension seen for individual lymph nodes therein after serial sectioning.
  • Find as many lymph nodes as you can in a specimen. Good locations to start include the presumed lymphatic drainage directions from a tumor, as well as when following the lymphatic directions from the vascular margins of a specimen. Serially section fatty tissue into slices that are thin enough to be palpated for small ovoid resistances. If you still have trouble finding enough lymph nodes, put fatty tissue in a vinegar and acetic acid solution made for the purpose of turning lymph nodes pale/white as well as making them more firm for palpation. Colon tumors are sometimes tattooed during endoscopy, and in such cases the tatoo ink often stains lymph nodes as well.

  • Gross pathology of a mesenteric lymph node.

  • Lymph node in partially inked mesorectal fat after a night in acetic acid.

  • Section lymph nodes if needed. Lymph nodes less than 5 mm may be submitted whole, while larger lymph nodes may be sectioned at 2-3 mm intervals.[1]
  • Generally do not submit multiple sectioned lymph nodes in the same cassette, to allow exact counting of the number of involved lymph nodes on microscopy. If you will nevertheless submit multiple bisected lymph nodes in the same cassette, ink each lymph node differently.
Making a "touch prep": Press a glass slide against the cut surface of the lymph node, apply cytologic fixative solution immediately and stain with H&E.
  • If suspected lymphoma, such as an enlarged lymph node without any adjacent tumor or another almost certain cause, make a touch prep. Also, take a small fresh sample for flow cytometry:
  • For flow cytometry, aim for a tissue size of approximately 5 mm3. Put it in specific flow cytometry preservative medium (such as RPMI), and ensure it gets to the flow cytometry lab. If it is after normal hours and there is no one to ask to find such medium, you can put the specimen in normal sterile saline (enough to cover the tissue) in a fridge (2-8°C) until the next morning.[2] If you receive multiple lymph nodes for flow cytometry, still only sample one (unless the referral asks for separate flow cytometry studies, or there is a given history of one lymph node having high uptake and another having low uptake on PET scanning).

Definition of an enlarged lymph node

Long and short axis.png
  • By size, where lymphadenopathy in adults is often defined as a short axis of one or more lymph nodes is greater than 10mm.[3][4] However, there is regional variation as detailed in this table:
Upper limit of lymph node sizes in adults
Generally 10 mm[3][4]
Inguinal 10[5] – 20 mm[6]
Pelvis 10 mm for ovoid lymph nodes, 8 mm for rounded[5]
Neck
Generally (non-retropharyngeal) 10 mm[5][7]
Jugulodigastric lymph nodes 11mm[5] or 15 mm[7]
Retropharyngeal 8 mm[7]
  • Lateral retropharyngeal: 5 mm[5]
Mediastinum
Mediastinum, generally 10 mm[5]
Superior mediastinum and high paratracheal 7mm[8]
Low paratracheal and subcarinal 11 mm[8]
Upper abdominal
Retrocrural space 6 mm[9]
Paracardiac 8 mm[9]
Gastrohepatic ligament 8 mm[9]
Upper paraaortic region 9 mm[9]
Portacaval space 10 mm[9]
Porta hepatis 7 mm[9]
Lower paraaortic region 11 mm[9]

Lymphadenopathy of the axillary lymph nodes can be defined as solid nodes measuring more than 15 mm without fatty hilum.[10] Axillary lymph nodes may be normal up to 30 mm if consisting largely of fat.[10]

In children, a short axis of 8 mm can be used.[11] However, inguinal lymph nodes of up to 15 mm and cervical lymph nodes of up to 20 mm are generally normal in children up to age 8–12.[12]

Lymphadenopathy of more than 1.5 cm - 2 cm increases the risk of cancer or granulomatous disease as the cause rather than only inflammation or infection.[13]

Urgency

The processing of lymph nodes is preferably rushed when the H&E stain will determine whether immunohistochemistry will be performed, especially when a lymph node is submitted together with a separate specimen that may be solved without immunostains. This rushing allows you to have the immunostained slides by a similar time as the rest of the case.[14] Examples of cases that are preferably rushed for such reasons include those that may be stained by CK AE1/AE3 in order to visualize otherwise occult lymph node involvement if you don't see any involvement on the H&E stain, mainly in cases when one or more sentinel lymph nodes are submitted together with any of the following:

Rushing is not necessary for non-sentinel lymph nodes.

Gross report

Individual lymph node, example
((A. Labeled - ___. The specimen is received in formalin and consists of)) __ fragment(s) of soft pink-tan tissue, measuring __ cm in greatest dimension (or __ x __ x __(. (Representative sections are submitted for microscopic examination in __ cassettes.)
Multiple lymph nodes
((A. Labeled - ___. The specimen is received fresh and consists of)) 2 irregular fragments of yellow-tan fatty and fibrous soft tissue measuring __ and ___ cm in greatest dimension. Within the adipose tissue are multiple tan-brown lymph nodes measuring up to __ cm in greatest dimension. The cut surfaces display no gross lesions. The lymph nodes are entirely submitted for microscopic examination (in 10 cassettes).
KEY TO SECTIONS:
  • A1–A3– one lymph node, serially section
  • A4-A5– one lymph node, serially sectioned
  • A6– one lymph node, bisected
  • A7– one lymph node, bisected
  • A8– two lymph nodes, each bisected, differentially inked
  • A9– one lymph node, bisected
  • A10– multiple lymph nodes.
Additional information
  • If potential breast cancer metastasis: The specimen was procured at __ AM/PM on (date), 2020. The specimen was placed in formalin at __ AM/PM on (date), 2020.
  • If lymphoma workup: A touch prep is made, and a minor part of the specimen is submitted for flow cytometry. The remainder of the specimen is submitted for microscopic examination in one cassette.

Microscopic examination

Defining a lymph node

For counting lymph nodes, each should have a discernible capsule around lymphoid cells. Also count larger free-standing lymphoid aggregates. However, the definition of what constitutes a lymph node is largely subjective.[15] Also strive to keep a consistency with the gross description. In addition, any cancer involvement is in itself a relative indication of being a lymph node.

General screening

Look for:

  • Whatever pathology is indicated by the referral, or findings in other submitted specimens.
  • Enlargement, as preferably measured during grossing, but can possibly be made on the microscopy slide. If present, see separate section below.

  • Metastases: generally first look around the edges with intermediate magnification, and low mag in the middle, since cancer metastases usually occur at edges (as in this case). For suspected urothelial cancers, however, look closely throughout the node, as they have a tendency to show up anywhere in lymph nodes.

  • Lymph node metastasis from a neuroendocrine tumor of the midgut. Metastates generally look similar to its primary tumor.

  • Granulomas (non-necrotizing granuloma pictured). If seen generally perform staining for acid-fast bacilli, and GMS stain for fungi.

Microscopy of enlarged lymph nodes

Look at any other slides for the same case first, in order to find any pathology that may be reflected in in the lymph nodes as well, mainly cancer metastasis or reactive lymph nodes from inflammation.

Look primarily at the overall architecture, with main findings being:

  • Follicular hyperplasia: Indicates mainly follicular hyperplasia of a reactive lymph node (pictured) or follicular lymphoma. Further information: Follicular hyperplasia

  • Dilated sinuses. The most cellular expansion is sinus histiocytosis (pictured). If it appears as such, look for a signet ring appearance, which may be a signet ring carcinoma or melanoma. If unsure, use immunostains for CD68, cytokeratin, S100 and mucin.[16]

  • Paracortical hyperplasia: Paracortical hyperplasia of a reactive lymph node shows expansion of paracortical areas by a mixed infiltrate, often having a mottled appearance, and it usually has a concomitant reactive follicular hyperplasia.[17] A T-cell lymphoma should be suspected if there is obliteration or marked diminution of the B-cell cortical region, or highly irregular or hyperchromatic nuclei.[17]
  • Unspecific hyperplasia: An unspecific pattern of lymph node enlargement, without atypical cells, in the lymphatic drainage direction from an inflamed area, may simply be diagnosed as "benign reactive lymph node".

Workup of cancerous lymph nodes

If cancer is detected in a lymph node:

  • Attempt to specify a specific cancer diagnosis'. If the patient has a known carcinoma or sarcoma etc, it is generally enough to confirm that it is consistent with a metastasis thereof.
  • Measure the size of involvement.
  • Look for extranodal extension.

Reporting

A non-involved lymph node in a patient with cancer can be reported for example as:

Sentinel lymph node #1, left axilla, (excision):
One benign lymph node((, negative for malignancy (0/1))).

Cancerous lymph nodes with patients with known consistent cancer primary can be reported as metastatic,, such as:

Sentinel lymph node #2, left axilla, (excision):
Macrometastatic carcinoma involving one of one (1/1) lymph node.
Metastatic carcinoma measures 0.4 cm in greatest dimension.
(Negative for extranodal extension).

Notes

  1. ↑ For a full list of contributors, see article history. Creators of images are attributed at the image description pages, seen by clicking on the images. See Patholines:Authorship for details.
  2. ↑ The duration that a specimen has been without formalin affects mainly the reliability of estreogen and progesteron receptor testing:
    - Pekmezci, Melike; Szpaderska, Anna; Osipo, Clodia; Erşahin, Çağatay (2012). "The Effect of Cold Ischemia Time and/or Formalin Fixation on Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor-2 Results in Breast Carcinoma ". Pathology Research International 2012: 1–7. doi:10.1155/2012/947041. ISSN 2090-8091. 

Main page

References

  1. ↑ . Protocol for the Examination of Biopsy Specimens From Patients With Melanoma of the Skin. College of American Pathologists. Version: Melanoma Biopsy 4.1.0.0 Protocol Posting Date: August 2019
  2. ↑ . Specimen Information and Requirements for Flow Cytometry Testing. Lifelabs. Doc #8218 Ver: 7.0 Current Issued: 13-Apr-2018
  3. ↑ 3.0 3.1 Ganeshalingam, Skandadas; Koh, Dow-Mu (2009). "Nodal staging ". Cancer Imaging 9 (1): 104–111. doi:10.1102/1470-7330.2009.0017. ISSN 1470-7330. PMID 20080453. 
  4. ↑ 4.0 4.1 Schmidt Júnior, Aurelino Fernandes; Rodrigues, Olavo Ribeiro; Matheus, Roberto Storte; Kim, Jorge Du Ub; Jatene, Fábio Biscegli (2007). "Distribuição, tamanho e número dos linfonodos mediastinais: definições por meio de estudo anatômico ". Jornal Brasileiro de Pneumologia 33 (2): 134–140. doi:10.1590/S1806-37132007000200006. ISSN 1806-3713. PMID 17724531. 
  5. ↑ 5.0 5.1 5.2 5.3 5.4 5.5 "Current concepts in lymph node imaging ". Journal of Nuclear Medicine 45 (9): 1509–18. September 2004. PMID 15347718. 
  6. ↑ . Assessment of lymphadenopathy. BMJ Best Practice. Retrieved on 2017-03-04. Last updated: Last updated: Feb 16, 2017
  7. ↑ 7.0 7.1 7.2 Page 432 in: Luca Saba (2016). Image Principles, Neck, and the Brain . CRC Press. ISBN 9781482216202. 
  8. ↑ 8.0 8.1 Sharma, Amita; Fidias, Panos; Hayman, L. Anne; Loomis, Susanne L.; Taber, Katherine H.; Aquino, Suzanne L. (2004). "Patterns of Lymphadenopathy in Thoracic Malignancies ". RadioGraphics 24 (2): 419–434. doi:10.1148/rg.242035075. ISSN 0271-5333. PMID 15026591. Archived from the original. . 
  9. ↑ 9.0 9.1 9.2 9.3 9.4 9.5 9.6 Dorfman, R E; Alpern, M B; Gross, B H; Sandler, M A (1991). "Upper abdominal lymph nodes: criteria for normal size determined with CT. ". Radiology 180 (2): 319–322. doi:10.1148/radiology.180.2.2068292. ISSN 0033-8419. PMID 2068292. 
  10. ↑ 10.0 10.1 Page 559 in: Wolfgang Dähnert (2011). Radiology Review Manual . Lippincott Williams & Wilkins. ISBN 9781609139438. 
  11. ↑ Page 942 in: Richard M. Gore, Marc S. Levine (2010). High Yield Imaging Gastrointestinal HIGH YIELD in Radiology . Elsevier Health Sciences. ISBN 9781455711444. 
  12. ↑ Laurence Knott. Generalised Lymphadenopathy. Patient UK. Retrieved on 2017-03-04. Last checked: 24 March 2014
  13. ↑ "Lymphadenopathy and malignancy ". American Family Physician 66 (11): 2103–10. December 2002. PMID 12484692. 
  14. ↑ Chandler IP, Oommen R, Lawson CW (2003). "Invasive lobular carcinoma and cytokeratin immunohistochemistry: an audit. ". J Clin Pathol 56 (3): 240. doi:10.1136/jcp.56.3.240. PMID 12610108. PMC: 1769908. Archived from the original. . 
  15. ↑ Parkash V, Bifulco C, Feinn R, Concato J, Jain D (2010). "To count and how to count, that is the question: interobserver and intraobserver variability among pathologists in lymph node counting. ". Am J Clin Pathol 134 (1): 42-9. doi:10.1309/AJCPO92DZMUCGEUF. PMID 20551265. Archived from the original. . 
  16. ↑ Egan, Caoimhe; Jaffe, Elaine S. (2018). "Non-neoplastic histiocytic and dendritic cell disorders in lymph nodes ". Seminars in Diagnostic Pathology 35 (1): 20–33. doi:10.1053/j.semdp.2017.11.002. ISSN 07402570. 
  17. ↑ 17.0 17.1 Weiss, Lawrence M; O'Malley, Dennis (2013). "Benign lymphadenopathies ". Modern Pathology 26 (S1): S88–S96. doi:10.1038/modpathol.2012.176. ISSN 0893-3952. 

Image sources


Retrieved from "https://patholines.org/index.php?title=Template:Lungs_and_lymph_nodes&oldid=6375"